氟特嗪胶囊治疗晚期胃癌的Ⅱ期临床研究

被引:18
作者
杨俊兰
焦顺昌
戴广海
李方
赵宏
李瑛
机构
[1] 中国人民解放军总医院肿瘤内科
[2] 中国人民解放军总医院肿瘤内科 北京市
关键词
氟特嗪胶囊; 顺铂; 晚期胃癌;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100112 [医学生物化学与分子生物学];
摘要
目的:以替加氟加顺铂为对照组,观察氟特嗪胶囊(FTQ)加顺铂,治疗晚期胃癌的安全性和有效性。方法:采用多中心、随机、单盲对照方法,共有226例晚期胃癌患者进入随机临床研究,其中191例患者可评价疗效。结果:试验组的有效率(31.31%对6.52%)、临床好转率(53.54%对23.91%)及临床受益率(90.91%对76.09%)均明显高于对照组。氟特嗪胶囊组的血液学毒性与替加氟组基本相同,但其消化道反应明显低于替加氟组。结论:氟特嗪胶囊加顺铂的联合方案是治疗晚期胃癌有效且安全的方案。
引用
收藏
页码:8 / 11
页数:4
相关论文
共 5 条
[1]
Doxifluridine combined with weekly paclitaxel for second-line treatment in patients with gastric cancer resistant to TS-1[J] Wataru Arai;Yoshinori Hosoya;Masanobu Hyodo;Hidenori Haruta;Kentaro Kurashina;Shin Saito;Yuuki Hirashima;Taku Yokoyama;Toru Zuiki;Kazuya Sakuma;Yoshikazu Yasuda;Hideo Nagai International Journal of Clinical Oncology 2007,
[2]
A phase I/II study of S-1 plus cisplatin in patients with advanced gastric cancer: 2-week S-1 administration regimen[J] Yasuhiro Sato;Hitoshi Kondo;Kana Honda;Daisuke Takahari;Tetsuya Sumiyoshi;Yasushi Tsuji;Naohito Yoshizaki;Yoshiro Niitsu International Journal of Clinical Oncology 2005,
[3]
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer[J] Shunichi Tsujitani;Kenji Fukuda;Nobuaki Kaibara Gastric Cancer 2003,
[4]
Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potentiation of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulators[J] Tetsuhiko Shirasaka;Yuji Shimamato;Hideyuki Ohshimo;Masahiro Yamaguchi;Toshiyuki Kato;Kazuhiko Yonekura;Masakazu Fukushima Anti-Cancer Drugs 1996,
[5]
An advancedpulmonary adenocarcinoma case in which TS-1 proved ef-fective Hayashi H;Mastushima Y;Kato H;et al; Gan To Kagaku Ryoho 2006,